scholarly journals Study of organisms isolation from acute bacterial conjunctivitis cases

2019 ◽  
Vol 5 (3) ◽  
pp. 318-321
Author(s):  
Sneh Gautam Rauth ◽  
◽  
Shadakshari S. Math ◽  
Author(s):  
Yuwaraj D. Kale ◽  
Sarika Choure

Abhishyanda is one of the Sarvagata Vyadhi mentioned by Acharya Sushruta. In modern science, signs and symptoms of Netrabhishyanda may be correlated with conjunctivitis, which is the inflammatory condition of conjunctiva. Kavala Dharana, Dhumrapana, Aschyotana, Sechana Putapaka etc. are various suggested regimens in Ayurvedic texts for the treatment of Netrabhishyanda. Considering this effectiveness of Palasha as mentioned by Acharya Sushruta, it is planned to study the use of Palasha Mula Arka Aschyotana in Pittaja Netrabhishyanda. 60 patients having classical signs and symptoms of Pittaja Abhishyanda (Acute Bacterial Conjunctivitis) as per Ayurvedic and modern texts were selected for the study. After completion of therapy, mean Conjunctival hyperemia was reduced to 0.2167 ± 0.4086 in Control and 0.5667 ± 0.5040 in Trial Group. Palasha Mula Arka was found effective in reduction in conjunctival hyperemia, watering and the number of culture colonies, it was also found effective in burning sensation, discharge, foreign body sensation and photophobia.


2020 ◽  
Vol 10 (2) ◽  
pp. 110
Author(s):  
Prithwijit Banerjee ◽  
Mita Chowdhury ◽  
Souradeep Ray ◽  
Soumya Chatterjee ◽  
Shreshtha Basak ◽  
...  

1986 ◽  
Vol 25 (10) ◽  
pp. 506-509 ◽  
Author(s):  
Pakit Vichyanond ◽  
Quinzetta Brown ◽  
Doug Jackson

1970 ◽  
Vol 54 (8) ◽  
pp. 540-547 ◽  
Author(s):  
L S Nakhla ◽  
M K al-Hussaini ◽  
A A Shokeir

2015 ◽  
Vol 6 (1) ◽  
pp. 63-65 ◽  
Author(s):  
A.P. Vignesh ◽  
Renuka Srinivasan ◽  
Swathi Karanth

Moxifloxacin is a widely used topical antibiotic in various bacterial infections of the eye. Its safety and efficacy have been proved by many studies. We report a case of a rare adverse effect following its use. A 10-year-old female who had presented with acute bacterial conjunctivitis in both eyes with no corneal involvement was started on preservative-free 0.5% topical moxifloxacin four times a day. The child developed a severe form of corneal toxicity in both eyes with circumcorneal congestion and corneal edema following its use. The child's visual acuity had dropped from 20/20 to 20/400 in both the eyes. Topical moxifloxacin was discontinued, following which the cornea cleared dramatically and the visual acuity became normal. This case indicates that though rare, topical moxifloxacin can cause severe keratitis and that more studies need to be conducted to evaluate its safety.


Sign in / Sign up

Export Citation Format

Share Document